LinkedIn Profile

Access OncoMed Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:omed 84273 Mar 23rd, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 34.00 Open Mar 23rd, 2024 12:02AM Mar 23rd, 2024 07:11PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 22nd, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 34.00 Open Mar 21st, 2024 11:53PM Mar 22nd, 2024 07:00PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 21st, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 34.00 Open Mar 21st, 2024 12:06AM Mar 21st, 2024 05:43PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 20th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 34.00 Open Mar 20th, 2024 12:46AM Mar 20th, 2024 07:44PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 19th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 34.00 Open Mar 18th, 2024 11:41PM Mar 19th, 2024 06:16PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 18th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 34.00 Open Mar 18th, 2024 12:02AM Mar 18th, 2024 07:29PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 16th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 35.00 Open Mar 15th, 2024 11:32PM Mar 16th, 2024 07:16PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 15th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 35.00 Open Mar 15th, 2024 01:21AM Mar 15th, 2024 09:06AM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 14th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 35.00 Open Mar 13th, 2024 11:30PM Mar 14th, 2024 12:27PM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:omed 84273 Mar 13th, 2024 12:00AM OncoMed Pharmaceuticals 5.0K 35.00 Open Mar 12th, 2024 11:25PM Mar 13th, 2024 10:58AM OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships. Open oncology, drug development, biotechnology, biopharmaceuticals, immuno-oncology, cancer stem cells, Redwood City, innovation, science, lung cancer, and pancreatic cancer Open 800 Chesapeake Dr. Redwood City CA US 94063 OncoMed Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.